| Literature DB >> 34287351 |
Vincenzo Di Stefano1, Andrea Gagliardo1, Filomena Barbone2, Michela Vitale2, Laura Ferri2, Antonino Lupica1, Salvatore Iacono1, Antonio Di Muzio3, Filippo Brighina1.
Abstract
The median-to-ulnar communicating branch (MUC) is an asymptomatic variant of the upper limb innervation that can lead to interpretation errors in routine nerve conduction studies. The diagnosis of carpal tunnel syndrome (CTS) or ulnar nerve lesions can be complicated by the presence of MUC. In this study, we describe electrophysiological features of MUC in CTS patients presenting to our clinic. We enrolled MUB cases from consecutive CTS patients referred to our laboratory between the years 2014 and 2019. MUC was present in 53 limbs (36 patients) from the studied population. MUC was bilateral in 53% of patients. MUC type II was the most common subtype (74%), followed by types III and I; more coexisting MUC types were found in the majority of tested limbs. A positive correlation was demonstrated between the severity of CTS and the presence of positive onset, faster CV, or a double component of the compound muscle action potentials. We emphasize the importance of suspecting the presence of MUC in CTS in the presence of a positive onset or a double component in routine motor conduction studies.Entities:
Keywords: Martin-Gruber anastomosis; carpal tunnel syndrome; median nerve; neurophysiology; ulnar nerve; ulnar neuropathy at elbow
Year: 2021 PMID: 34287351 PMCID: PMC8293426 DOI: 10.3390/neurolint13030031
Source DB: PubMed Journal: Neurol Int ISSN: 2035-8385
Comparison among different types of median-to-ulnar communicating branch according to MUC classifications.
| Type of Communication | Frequency in Healthy Subjects | Distribution | Clinical Suspicion | NCS Findings | Possible Misdiagnosis |
|---|---|---|---|---|---|
| MUC type I | 2–44% | Proximal median to distal ulnar communication innervating the hypothenar muscles. | Absence of hypothenar involvement in the presence of ulnar nerve damage. | Greater CMAP amplitude over ADM recording when stimulating the ulnar nerve at the wrist | Ulnar neuropathy at the elbow/cubital tunnel syndrome |
| MUC type II | 8–58% | Proximal median to distal ulnar communication innervating the FDI muscle. | Absence of FDI involvement in the presence of ulnar nerve damage. | Greater CMAP amplitude over FDI recording when stimulating the ulnar nerve at the wrist | Ulnar neuropathy at the elbow/cubital tunnel syndrome |
| MUC type III | 0.01–30% | Proximal median to distal ulnar communication innervating the thenar muscles | Absence of thenar involvement in the presence of median nerve damage. | Greater CMAP amplitude over APB recording when stimulating the median nerve at the elbow compared to the wrist. | Carpal tunnel syndrome |
MUC—median-to-ulnar communicating branch; NCS—nerve conduction studies; FDI—first dorsal interosseus muscle; ADM—abductor digiti minimi muscle; APB—abductor brevis pollicis muscle.
Electrodiagnostic criteria for median-to-ulnar communicating branch.
|
Proximal MN evoked CMAP higher at least 2 mV than distal one |
|
Initial positive deflection or presence of double component in the MN evoked CMAP at proximal stimulation site recording by ABP |
|
MN motor CV over 75 m/s at proximal site of stimulation |
|
Distal UN evoked CMAP recorded from ADM or FDI higher at least 2 mV than proximal one |
|
Presence of a measurable potential recording from ADM with proximal MN stimulation |
MN—median nerve; UN—ulnar nerve; CMAP—compound motor action potential; CV—conduction velocity; ADM—abductor digit minimi muscle; FDI—first dorsal interosseus muscle.
Features of median-to-ulnar communicating branch in 36 patients with carpal tunnel syndrome and MUC. MUC—median-to-ulnar communicating branch.
| MUC I | MUC II | MUC III | Total (Limbs) | |
|---|---|---|---|---|
| Limbs ( | 18 (34%) | 39 (74%) | 32 (60%) | 53 |
| Sex (males, %) | 2 (11%) | 6 (15%) | 4 (13%) | 9 (17%) |
| Side (right, %) | 8 (44%) | 19 (49%) | 20 (63%) | 28 (53%) |
| Isolated communication ( | 0 | 10 (26%) | 11 (34%) | 21 (40%) |
| Coexistent MUC I ( | / | 18 (46%) | 9 (28%) | / |
| Coexistent MUC II ( | 18 (100%) | / | 20 (63%) | / |
| Coexistent MUC III ( | 9 (50%) | 20 (51%) | / | / |
Nerve conduction studies in patients with carpal tunnel syndrome and median-to-ulnar communicating branch. Values are expressed as means with standard deviations or percentages.
| Recording Site | MUC I | MUC II | MUC III | Total Limbs |
|---|---|---|---|---|
|
| ||||
| DML (ms) | 2.8 ± 0.6 | 2.8 ± 0.5 | 2.7 ± 0.5 | 2.7 ± 0.5 |
| CMAP-AW (mV) | 10.5 ± 2.3 | 10.5 ± 2.4 | 10.8 ± 2.0 | 10.6 ± 2.3 |
| CMAP-AE (mV) | 8.9 ± 2.4 | 9.1 ± 2.4 | 9.2 ± 2.2 | 9.1 ± 2.3 |
| CV (m/s) | 58.0 ± 7.6 | 57.8 ± 4.9 | 59.5 ± 4.7 | 58.7 ± 6.9 |
| Positive onset ( | 2 (11%) | 2 (5%) | 1 (3%) | 4 (8%) |
| Double component ( | 0 | 0 | 0 | 0 |
| Ulnar Gain in amplitude mV (%) | 1.7 ± 0.7 (21%) | 1.2 ± 0.9 (19%) | 1.4 ± 0.8 (22%) | 1.2 ± 0.9 (19%) |
|
| ||||
| DML (ms) | 5.6 ± 2.0 | 5.1 ± 1.9 | 5.2 ± 2.2 | 5.1 ± 1.9 |
| CMAP-AW (mV) | 0.2 ± 0.6 | 0.3 ± 0.6 | 0.4 ± 0.7 | 0.3 ± 0.6 |
| CMAP-AE (mV) | 1.1 ± 0.7 | 0.9 ± 0.7 | 0.7 ± 0.7 | 0.8 ± 0.7 |
| Positive onset ( | 6 (33%) | 6 (15%) | 3 (9%) | 15 (28%) |
| Double component ( | 0 | 0 | 0 | 0 |
| Median drop in amplitude mV (%) | 0.9 ± 0.4 (86%) | 0.5 ± 0.5 (73%) | 0.3 ± 0.4 (63%) | 0.4 ± 0.5 (73%) |
|
| ||||
| DML (ms) | 3.4 ± 0.3 | 3.5 ± 0.4 | 3.6 ± 0.5 | 3.5 ± 0.4 |
| CMAP-AW (mV) | 11.9 ± 4.7 | 11.2 ± 4.4 | 10.4 ± 3.8 | 11.3 ± 4.4 |
| CMAP-AE (mV) | 7.1 ± 4.0 | 7.0 ± 3.7 | 6.8 ± 3.3 | 7.3 ± 3.9 |
| CV (m/s) | 55.8 ± 5.8 | 54.3 ± 7.1 | 52.6 ± 6.6 | 54.6 ± 6.9 |
| Positive onset ( | 2 (11%) | 3 (8%) | 0 | 4 (8%) |
| Double component ( | 0 | 0 | 0 | 0 |
| Ulnar Gain in amplitude mV (%) | 4.9 ± 2.4 (93%) | 4.1 ± 2.0 (80%) | 3.4 ± 1.5 (67%) | 3.9 ± 1.1 (73%) |
|
| ||||
| DML (ms) | 4.7 ± 0.8 | 4.9 ± 1.1 | 5.3 ± 1.5 | 4.8 ± 1.1 |
| CMAP-AW (mV) | 0.6 ± 4.0 | 0.7 ± 0.6 | 0.8 ± 1.2 | 0.8 ± 0.9 |
| CMAP-AE (mV) | 4.0 ± 2.6 | 3.6 ± 2.2 | 3.5 ± 2.0 | 3.5 ± 2.2 |
| Positive onset ( | 0 | 0 | 0 | 0 |
| Double component ( | 0 | 0 | 0 | 0 |
| Median drop in amplitude mV (%) | 3.3 ± 2.0 (81%) | 2.9 ± 1.7 (79%) | 2.6 ± 1.4 (73%) | 2.7 ± 1.6 (74%) |
|
| ||||
| DML (ms) | 5.3 ± 2.6 | 5.2 ± 2.2 | 6.2 ± 2.4 | 5.3 ± 2.2 |
| CMAP-AW (mV) | 7.1 ± 3.1 | 7.0 ± 3.5 | 5.0 ± 3.4 | 6.3 ± 3.7 |
| CMAP-AE (mV) | 7.1 ± 3.0 | 7.4 ± 3.6 | 5.4 ± 3.4 | 6.6 ± 4.0 |
| CV (m/s) | 99.9 ± 58.7 | 103.1 ± 118.7 | 172.8 ± 113.8 | 123 ± 145 |
| Positive onset ( | 12 (67%) | 22 (56%) | 28 (88%) | 35 (66%) |
| Double component ( | 3 (17%) | 5 (13%) | 11 (34%) | 12 (23%) |
| Median drop in amplitude mV (%) | 0.1 ± 0.5 (1%) | 0.4 ± 0.7 (5%) | 0.5 ± 0.7 (6%) | 0.5 ± 0.7 (5%) |
|
| ||||
| DML (ms) | 3.1 ± 0.8 | 3.3 ± 0.8 | 3.2 ± 0.7 | 3.2 ± 0.7 |
| CMAP-AW (mV) | 4.2 ± 1.5 | 4.5 ± 2.0 | 4.3 ± 1.8 | 4.6 ± 2.2 |
| CMAP-AE (mV) | 3.6 ± 1.4 | 3.7 ± 1.5 | 3.6 ± 1.4 | 3.8 ± 1.6 |
| Positive onset ( | 3 (17%) | 9 (23%) | 9 (28%) | 11 (21%) |
| Double component ( | 0 | 0 | 0 | 0 |
| Ulnar Gain in amplitude mV (%) | 0.5 ± 0.6 (19%) | 0.7 ± 0.7 (21%) | 0.8 ± 0.6 (24%) | 0.7 ± 0.7 (21%) |
MUC—median-to-ulnar communicating branch; ADM—abductor digiti minimi muscle; FDI—first dorsal interosseus muscle; APB—abductor brevis pollicis muscle; CMAP-AW/E—compound motor action potential at the wrist/elbow; ADM ulnar nerve—ulnar nerve stimulation while recording from ADM muscle; ADM median nerve—median nerve stimulation while recording from ADM muscle; FDI ulnar nerve—ulnar nerve stimulation while recording from FDI muscle; FDI median nerve—median nerve stimulation while recording from FDI muscle; APB median nerve—median nerve stimulation while recording from APB muscle; APB ulnar nerve—ulnar nerve stimulation while recording from APB muscle; DML—distal motor latency; CV—conduction velocity.
Figure 1Correlation between DML, double potential, and CV in patients with MUC and CTS. (A) The linear correlation between median nerve CV and DML from NCS recording from APB. (B) The distribution of double potentials among MUC patients depending on the DML of the median nerve. MUC—median-to-ulnar communicating branch; CTS—carpal tunnel syndrome; CV—conduction velocity; DML—distal motor latency; NCS—nerve conduction studies; APB—abductor brevis pollicis muscle; * p < 0.0001.
Figure 2Motor nerve conduction studies from patients with MUC type I (A), II (B), and III (C). (A) Recording from ADM, a difference of 3.1 mV was recognizable between U-W and U-BE and an MUC component of 1.8 mV was demonstrated. (B) Recording from FDI, a significant drop of 7.4 mV between U-W and U-BE corresponded to a MUC of 6.8 mV, as demonstrated upon ME stimulation. (C) A positive onset was evident upon ME but not MW stimulation. MUC—median-to-ulnar communicating branch; ADM—abductor digiti minimi muscle; FDI—first dorsal interosseus muscle; APB—abductor brevis pollicis muscle; U-W—ulnar wrist; U-BE—ulnar below elbow; MW—median wrist; ME—median elbow.
Figure 3Motor nerve conduction studies from patients with MUC type III and severe CTS. (A) A significant positive onset was evident upon ME but not at MW stimulation. (B–D) A double component was demonstrated upon ME stimulation. (B,C) The more prolonged the DLM was, the more the two components were spaced apart until they were even separated from the baseline (D). MUC—median-to-ulnar communicating branch; APB—abductor brevis pollicis muscle; MW—median wrist; ME—median elbow; DML—distal motor latency.